-
Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder
04/22/2026
See how an antisense oligonucleotide reverses ultrarare X-linked genetic condition HNRNPH2-related neurodevelopmental disorder in preclinical study
-
Enhancer provides a potential target for “undruggable” MYC in pediatric medulloblastoma
04/22/2026
Learn how St. Jude researchers identified a tumor-specific enhancer driving MYC in pediatric medulloblastoma, revealing a promising new therapeutic target.
-
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital award 2026 fellowships
04/21/2026
Early-career investigators studying pediatric cancers, including Ewing sarcoma, leukemia and kidney cancer, were selected this year.
-
‘Fingerprints’ of childhood cancer treatment provide clues that may help mitigate second cancers
04/19/2026
Learn how new research of the traces life-saving pediatric cancer treatments leave in DNA could help improve the detection and prevention of second neoplasms.
-
3D tumor organoids give brain tumor researchers new scientific opportunities
04/15/2026
Learn about brain tumor organoids developed by St. Jude scientists that preserve tumor diversity, enabling faster research and better access to research models
-
First continent-wide map of dominant avian influenza strain explains its spread
04/15/2026
Find out how mapping the spread of an avian influenza strain through birds across North America helped scientists understand its human-to-human spread risk.
-
AACR annual meeting highlights St. Jude research, honors Comprehensive Cancer Center director
04/14/2026
Several St. Jude researchers featured at AACR 2026
-
Study identifies PHIP as a novel dependency in cancers driven by SWI/SNF mutations
04/07/2026
Discover research from St. Jude identifying PHIP as a novel dependency in cancers that have mutations in SWI/SNF
-
Data platform unifies blood cancer ‘omics’ and clinical data to accelerate discovery
04/06/2026
Take a first look at the American Society of Hematology HematOmics Program (ASHOP) platform & its promise to move hematological malignancy research forward.
-
Childhood cancer is a substantial contributor to global childhood mortality and global cancer burden
04/02/2026
Explore how global disparities in childhood cancer outcomes reveal urgent gaps in care, and what it will take to close the survival gap worldwide.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.